OXYMORPHONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Oxymorphone, and when can generic versions of Oxymorphone launch?
Oxymorphone is a drug marketed by Actavis Elizabeth, Hikma, Impax Labs, Par Pharm, Specgx Llc, Sun Pharm Inds Ltd, Ascent Pharms Inc, Aurolife Pharma Llc, Avanthi Inc, Epic Pharma Llc, and Teva. and is included in thirteen NDAs.
The generic ingredient in OXYMORPHONE is oxymorphone hydrochloride. There are nine drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the oxymorphone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Oxymorphone
A generic version of OXYMORPHONE was approved as oxymorphone hydrochloride by IMPAX LABS on June 14th, 2010.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for OXYMORPHONE?
- What are the global sales for OXYMORPHONE?
- What is Average Wholesale Price for OXYMORPHONE?
Summary for OXYMORPHONE
| US Patents: | 0 |
| Applicants: | 11 |
| NDAs: | 13 |
| Drug Prices: | Drug price information for OXYMORPHONE |
| DailyMed Link: | OXYMORPHONE at DailyMed |


